HRMY compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

HRMYHarmony Biosciences Holdings, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

HRMYHarmony Biosciences Holdings, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

HRMY

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±12.9%▼−7.04%×0.54

Q2 FY26±14.3%▲+8.93%×0.62

May 7 '26±12.0%▼−4.15%×0.35

Q1 FY26±14.4%▲+4.91%×0.34

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedHRMY realized, solidLLY realized, hatchedOne scale, both sides: full bar = 15%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

HRMYHarmony Biosciences Holdings, Inc.

33.09▲+1.91%· post 33.09

Mkt cap$1.9BRevenue$269MQ3 FY26Revenue$868MFY25

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

ClosedNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 6 '26

HRMYHarmony Biosciences Holdings, Inc.

LLYELI Lilly & Co

33.09▲+1.91%post 33.09

Price

1,360.90▼−0.28%post 1,358.90

$1.9B

Mkt cap

$1.2T

Q3 FY26$269M

Revenue

$24.4BQ3 FY26

FY25$868M

Revenue

$65.2BFY25

HRMY33.09▲+1.91%vsLLY1,360.90▼−0.28%ClosedNov 6 '26